63 Views | 35 Downloads
Lucy B. Spalluto, MD MPH, Department of Radiology, 1161 21st Avenue, South, Nashville, TN 37232, Telephone: (615) 322-1585, Fax: (615) 343-0746, Email: lucy.b.spalluto@vumc.org
All authors substantially contributed to the design of the work, the writing and revision of the manuscript, approved the final version of the manuscript and are accountable for the manuscript’s contents.
LBS, JAL, and CCL serve on the Steering Committee for this VAMC lung screening program. JAL and CCL are clinical co-directors of the clinical lung cancer screening program. Neither receive financial compensation for these roles. CGS is the co-director of his facility’s lung cancer screening program and does not receive financial compensation for that role.
FY is a named inventor on a number of patents and patent applications relating to the evaluation of diseases of the chest including measurement of nodules. Some of these, which are owned by Cornell Research Foundation (CRF), are non-exclusively licensed to General Electric. As an inventor of these patents, DFY is entitled to a share of any compensation which CRF may receive from its commercialization of these patents. He is also an equity owner in Accumetra, a privately held technology company committed to improving the science and practice of image-based decision making. DFY also serves on the advisory board of GRAIL.
CIH is the President and serves on the board of the Early Diagnosis and Treatment Research Foundation. She receives no compensation from the Foundation. The Foundation is established to provide grants for projects, conferences, and public databases for research on early diagnosis and treatment of diseases. CIH is also a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on CT scans of the chest which are owned by Cornell Research Foundation (CRF). Since 2009, CIH does not accept any financial benefit from these patents including royalties and any other proceeds related to the patents or patent applications owned by CRF.
This study was supported in part by the VA Office of Rural Health (LBS, JAL, CLR), Office of Academic Affiliations, Department of Veterans Affairs, VA National Quality Scholars Program (JAL, CLR,) with resources and use of facilities at VA Tennessee Valley Healthcare System, Nashville TN (LBS, JAL, VMY, CCL, CLR, PPM), the VA Boston Healthcare System (RSW), the VA Portland Health Care System (CGS), and the Phoenix Veterans Healthcare System (CIH).
The study was also supported in part by the Vanderbilt-Ingram Cancer Center Support Grant CA68485 (LBS, JAL, PPM), Vanderbilt Scholars in T4 Translational Research (VSTTaR) K12 Program, funded by the National Heart, Lung, and Blood Institute K12HL137943 (JAL and CLR) and Agency for Healthcare Research and Quality K01 HS25486-01 (DS) and Agency for Healthcare Research and Quality/Patient Centered Outcomes Research Institute K12 HS026395 (TV and CLR).